4.8 Article

Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes

期刊

NEURON
卷 96, 期 1, 页码 115-+

出版社

CELL PRESS
DOI: 10.1016/j.neuron.2017.09.003

关键词

-

资金

  1. NIH [R01AG035355, R37AG027924, RF1AG051504, R01AG046205]
  2. Cure Alzheimer's Fund
  3. BrightFocus Foundation [A2016346F]
  4. Alzheimer's Association [AARG-17-500335]
  5. Mayo Clinic Alzheimer's Disease Research Center [P50AG016574]
  6. Mayo Clinic

向作者/读者索取更多资源

Diabetes and impaired brain insulin signaling are linked to the pathogenesis of Alzheimer's disease (AD). The association between diabetes and AD-associated amyloid pathology is stronger among carriers of the apolipoprotein E (APOE) epsilon 4 gene allele, the strongest genetic risk factor for late-onset AD. Here we report that apoE4 impairs neuronal insulin signaling in human apoE-targeted replacement (TR) mice in an age-dependent manner. High-fat diet (HFD) accelerates these effects in apoE4-TR mice at middle age. In primary neurons, apoE4 interacts with insulin receptor and impairs its trafficking by trapping it in the endosomes, leading to impaired insulin signaling and insulin-stimulated mitochondrial respiration and glycolysis. In aging brains, the increased apoE4 aggregation and compromised endosomal function further exacerbate the inhibitory effects of apoE4 on insulin signaling and related functions. Together, our study provides novel mechanistic insights into the pathogenic mechanisms of apoE4 and insulin resistance in AD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据